Video Experimental Relacionado
Updated: May 11, 2026
06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.6K
Desafíos Actuales en el Manejo de Dispositivos Cardíacos: Guía para Clínicos en Ejercicio: Un Documento de Posición
Jacqueline Joza1, Francois Philippon2, Derek S Chew3
1Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada. Electronic address: https://x.com/Dr_JozaEP.
The Canadian journal of cardiology
|January 15, 2026
Resumen
Los dispositivos electrónicos implantables cardíacos (CIED) controlan el ritmo cardíaco, pero los ensayos clínicos van a la zaga de los avances tecnológicos. Esta revisión aborda las lagunas de evidencia en los CIED para mejorar la atención al paciente y la toma de decisiones.
Área de la Ciencia:
- Cardiología
- Ingeniería Biomédica
Sus antecedentes:
- Los dispositivos electrónicos implantables cardíacos (CIED) son cruciales para el manejo de la frecuencia y el ritmo cardíacos.
- Los CIED incluyen marcapasos, desfibriladores cardioversores implantables, dispositivos de terapia de resincronización cardíaca (TRC) y monitores cardíacos implantables.
Objetivo del estudio:
- Evaluar críticamente la literatura sobre las lagunas de evidencia en los CIED.
- Fomentar el diálogo entre las partes interesadas para generar evidencia que mejore la toma de decisiones clínicas y los resultados de los pacientes.
Principales métodos:
- Evaluación de la literatura sobre la evidencia actual en relación con los CIED.
- Revisión y evaluación experta de las lagunas de evidencia identificadas.
Principales resultados:
- Los avances técnicos en los CIED han superado los ensayos clínicos robustos en varias áreas clave.
- Las lagunas de evidencia identificadas incluyen CIED de prevención primaria en insuficiencia cardíaca, estratificación de riesgos en miocardiopatías, estimulación del sistema de conducción, impacto de la insuficiencia tricuspidea, CIED en intervenciones valvulares estructurales y sistemas de CIED sin cables.
Conclusiones:
- Existe una necesidad crítica de generar evidencia en áreas específicas de la tecnología y aplicación de los CIED.
- Abordar estas lagunas de evidencia es esencial para refinar la toma de decisiones clínicas y mejorar los resultados de los pacientes en la atención cardiovascular.
Palabras clave:
terapia de resincronización cardíacaestimulación del sistema de conduccióndesfibriladormarcapasosmuerte súbita cardíacaimplante de válvula aórtica transcatéterinsuficiencia tricuspideaMás Videos Relacionados
Videos de Conceptos Relacionados
01:26Cardiac Catheterization IV: Nursing Management
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
01:26Acute Coronary Syndrome V: Nursing Management
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:29Cardiomyopathy VI: Nursing Management
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...